BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11418697)

  • 1. A retro-inverso peptide mimic of CD28 encompassing the MYPPPY motif adopts a polyproline type II helix and inhibits encephalitogenic T cells in vitro.
    Srinivasan M; Wardrop RM; Gienapp IE; Stuckman SS; Whitacre CC; Kaumaya PT
    J Immunol; 2001 Jul; 167(1):578-85. PubMed ID: 11418697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28.
    Srinivasan M; Gienapp IE; Stuckman SS; Rogers CJ; Jewell SD; Kaumaya PT; Whitacre CC
    J Immunol; 2002 Aug; 169(4):2180-8. PubMed ID: 12165548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
    Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis.
    Perrin PJ; June CH; Maldonado JH; Ratts RB; Racke MK
    J Immunol; 1999 Aug; 163(3):1704-10. PubMed ID: 10415078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD80 binding polyproline helical peptide inhibits T cell activation.
    Srinivasan M; Lu D; Eri R; Brand DD; Haque A; Blum JS
    J Biol Chem; 2005 Mar; 280(11):10149-55. PubMed ID: 15598660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of encephalitogenic T cells with recombinant TCR ligands.
    Burrows GG; Adlard KL; Bebo BF; Chang JW; Tenditnyy K; Vandenbark AA; Offner H
    J Immunol; 2000 Jun; 164(12):6366-71. PubMed ID: 10843691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
    J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism.
    Engelhardt JJ; Sullivan TJ; Allison JP
    J Immunol; 2006 Jul; 177(2):1052-61. PubMed ID: 16818761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
    Burrows GG; Bebo BF; Adlard KL; Vandenbark AA; Offner H
    J Immunol; 1998 Dec; 161(11):5987-96. PubMed ID: 9834080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell recognition of distinct peptide:I-Au conformers in murine experimental autoimmune encephalomyelitis.
    Huang JC; Han M; Minguela A; Pastor S; Qadri A; Ward ES
    J Immunol; 2003 Sep; 171(5):2467-77. PubMed ID: 12928395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice.
    Grogan JL; Kramer A; Nogai A; Dong L; Ohde M; Schneider-Mergener J; Kamradt T
    J Immunol; 1999 Oct; 163(7):3764-70. PubMed ID: 10490973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
    Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
    J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of experimental autoimmune encephalomyelitis in SJL mice by oral administration of retro-inverso derivative of encephalitogenic epitope P87-99.
    Marino M; Ippolito A; Fassina G
    Eur J Immunol; 1999 Aug; 29(8):2560-6. PubMed ID: 10458771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.
    Wang C; Mooney JL; Meza-Romero R; Chou YK; Huan J; Vandenbark AA; Offner H; Burrows GG
    J Immunol; 2003 Aug; 171(4):1934-40. PubMed ID: 12902496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigens hyperinduce inflammatory cytokines by enhancing the B7-2/CD28 costimulatory receptor interaction.
    Levy R; Rotfogel Z; Hillman D; Popugailo A; Arad G; Supper E; Osman F; Kaempfer R
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6437-E6446. PubMed ID: 27708164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II peptide flanking residues of exogenous antigens influence recognition by autoreactive T cells.
    Conant SB; Swanborg RH
    Autoimmun Rev; 2003 Jan; 2(1):8-12. PubMed ID: 12848969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
    J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis.
    Kumar V; Aziz F; Sercarz E; Miller A
    J Exp Med; 1997 May; 185(10):1725-33. PubMed ID: 9151697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.